Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 16, 2007 - Issue 10
Submit an article Journal homepage
49
Views
0
CrossRef citations to date
0
Altmetric
Meeting Highlights

67th Annual Meeting of the American Diabetes Association

Jerry R Colca Metabolic Solutions Development Co., 125 S. Kalamazoo Mall #202, Kalamazoo, Michigan 49007, USA +1 269 343 6732; +1 269 343 6742; [email protected]
Pages 1735-1739 | Published online: 09 Oct 2007

Bibliography

  • BRAY GM: Exenatide. Am. J. Health Syst. Pharm. (2006) 63:411-418.
  • HARDER H, NIELSEN L, THI TDT, ASTRUP A: The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic control, body composition, and 24-h energy expenditure in patients with Type 2 diabetes. Diabetes Care (2004) 27:1915-1921.
  • DRUCKER DJ: Enhancing incretin action for the treatment of Type 2 diabetes. Diabetes Care (2003) 26:2929-2940.
  • YKI-JARVINEN H: Thiazolidinediones. N. Engl. J. Med. (2004) 351:1106-1118.
  • GEGICK CG, ALTHEIMER MD: Comparison of effects of thiazolidinediones on cardiovascular risk factors: observations from a clinical practice. Endocr. Pract. (2001) 7:162-169.
  • ERDMANN E, DORMANDY JA, CHARBONNEL B, MASSI-BENEDETTI M, MOULES IK, SKENE AM: The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with Type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) study. J. Am. Coll. Cardiol. (2007) 49(17):1772-1780.
  • SIDHU JS, KAPOSZTA Z, MARKUS HS, KASKI JC: Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. (2004) 24:930-934.
  • GOLDBERG RB, KENDALL DM, DEEG MA et al.: A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with Type 2 diabetes and dyslipidemia. Diabetes Care (2005) 28:1547-1554.
  • GUAN Y, HAO C, CHA DR et al.: Thiazolidinediones expand body fluid volume through PPARγ stimulation of ENaC-mediated renal salt absorption. Nat. Med. (2005) 11:861-866.
  • DAVIDSON MB: Clinical implications of the DREAM study. Diabetes Care (2007) 30:418-420.
  • NISSEN SE, WOLSKI K: Effects of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N. Engl. J. Med. (2007) 356(24):2457-2471.
  • HOME PD, JONES NP, POCOCK SJ et al.: Rosiglitazone RECORD study: glucose control outcomes at 18 months. Diabet. Med. (2007) 24(6):626-634.
  • GREGOR MG, HOTAMISLIGIL GS. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J. Lipid Res. (2007) 48:1905-1914.
  • MCLAUGHLIN T, SHERMAN A, TSAO P et al.: Enhanced proportion of small adipose cells in insulin-resistant versus insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia (2007) 50(8):1707-1715.
  • KOVES TR, LI P, AN J et al.: Peroxisome proliferator-activated receptor- co-activator 1-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J. Biol. Chem. (2005) 280:33588-33598.
  • COLCA JR: Discontinued drugs 2005: endocrine and metabolic. Expert Opin. Investig. Drugs (2007) 16(2):129-136.
  • COLCA JR: Discontinued drugs 2006: endocrine and metabolic. Expert Opin. Investig. Drugs (2007) 16(10):1517-1523.
  • COLCA JR, KLETZIEN RF: What has prevented the expansion of the insulin sensitizers? Expert Opin. Investig. Drugs (2006) 15(3):205-210.
  • COLCA JR: Insulin sensitizers may prevent metabolic inflammation. Biochem. Pharmacol. (2006) 72:125-131.

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.